Emmaus secures $30 mln from GPB Capital

GPB Capital has made a $30 million debt investment in Emmaus Life Sciences Inc. Based in Torrance, California, Emmaus is a developer of treatments and therapies for rare and orphan diseases.

18 January 2018•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles